Please login to the form below

Not currently logged in

DH invites proposals for genetics funding

DH and the Wellcome Trust are inviting proposals from organisations and research groups for funding from the Health Innovation Challenge Fund

The Department of Health (DH) and the Wellcome Trust are inviting proposals from organisations and research groups seeking to draw on funding from the Health Innovation Challenge Fund. 'Advancing Genetic Discoveries into Clinical Practice' is the first area of expertise to be offered funding, with up to £20m.

Medical genetics is the first of a number of areas that the Health Innovation Challenge Fund will offer funding for. The aim of the cash injection is to help capitalise on the wealth of information created by human genome analysis and to bring the emerging insights to clinical application. The Health Innovation Challenge Fund can support initiatives for up to five years and has a total of up to £100m available, contributed in equal measure by the DH and the Wellcome Trust.

The purpose of the Health Innovation Challenge Fund is to facilitate high-quality technological developments that can deliver economic and patient health benefits and build on the UK's excellence in science. The initiative will stimulate the delivery of technologies, products and interventions having clinical applicability within the NHS.

20th July 2009

From: Healthcare


COVID-19 Updates and Daily News

Featured jobs


Add my company
Merrill Brink International

Merrill Brink International is a leading provider of life sciences, legal, financial, manufacturing and corporate language solutions for global companies....

Latest intelligence

What challenges still face clinical trial recruitment and retention?
Discover the reasons for the current clinical trial recruitment challenges facing pharma and the life sciences industry, and how the search for solutions to the problem continues...
“Fake News” and Credibility in Medical Publishing
Natalie Yeadon from Impetus Digital shares her thoughts on fighting fake news in Pharma and healthcare....
Delivering true value: what does it mean for KAM in cancer care?
Lisa Alderson, Business Development Director at Wilmington Healthcare, explores the challenges that pharma’s KAM teams face in engaging with the NHS and how they must evolve...